Electromed Inc (NYSE MKT:ELMD) — Market Cap & Net Worth
Market Cap & Net Worth: Electromed Inc (ELMD)
Electromed Inc (NYSE MKT:ELMD) has a market capitalization of $222.85 Million ($222.85 Million) as of September 17, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #16215 globally and #3861 in its home market, demonstrating a 4.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Electromed Inc's stock price $38.22 by its total outstanding shares 8275313 (8.28 Million). Also see ELMD asset base for a full breakdown of the balance sheet.
Electromed Inc Market Cap History: 2015 to 2026
Electromed Inc's market capitalization history from 2015 to 2026. Data shows growth from $15.72 Million to $316.28 Million (33.14% CAGR). Also see ELMD cash flow metrics for how efficiently the company converts equity into cash flow.
Electromed Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Electromed Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Electromed Inc (ELMD) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.77x
Electromed Inc's market cap is 3.77 times its annual revenue
Latest Price to Earnings (P/E) Ratio
31.97x
Electromed Inc's market cap is 31.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $32.11 Million | $22.99 Million | $2.21 Million | 1.40x | 14.51x |
| 2017 | $50.23 Million | $25.86 Million | $2.23 Million | 1.94x | 22.53x |
| 2018 | $42.12 Million | $28.31 Million | $1.83 Million | 1.49x | 23.00x |
| 2019 | $71.58 Million | $31.30 Million | $1.98 Million | 2.29x | 36.15x |
| 2020 | $81.18 Million | $32.47 Million | $4.16 Million | 2.50x | 19.51x |
| 2021 | $107.58 Million | $35.76 Million | $2.36 Million | 3.01x | 45.55x |
| 2022 | $86.81 Million | $41.66 Million | $2.31 Million | 2.08x | 37.66x |
| 2023 | $90.28 Million | $48.07 Million | $3.17 Million | 1.88x | 28.52x |
| 2024 | $244.54 Million | $54.72 Million | $5.15 Million | 4.47x | 47.48x |
| 2025 | $240.98 Million | $64.00 Million | $7.54 Million | 3.77x | 31.97x |
Competitor Companies of ELMD by Market Capitalization
Companies near Electromed Inc in the global market cap rankings as of September 17, 2026. Review Electromed Inc (ELMD) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Electromed Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Electromed Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Electromed Inc's market cap moved from $15.72 Million to $ 316.28 Million, with a yearly change of 33.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $316.28 Million | +31.25% |
| 2025 | $240.98 Million | -1.46% |
| 2024 | $244.54 Million | +170.85% |
| 2023 | $90.28 Million | +4.00% |
| 2022 | $86.81 Million | -19.31% |
| 2021 | $107.58 Million | +32.52% |
| 2020 | $81.18 Million | +13.41% |
| 2019 | $71.58 Million | +69.94% |
| 2018 | $42.12 Million | -16.14% |
| 2017 | $50.23 Million | +56.44% |
| 2016 | $32.11 Million | +104.21% |
| 2015 | $15.72 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Electromed Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $222.85 Million USD |
| MoneyControl | $222.85 Million USD |
| MarketWatch | $222.85 Million USD |
| marketcap.company | $222.85 Million USD |
| Reuters | $222.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more